The KRAS Codon 61 Mutation Detection Test is a specialized diagnostic procedure aimed at identifying mutations in codon 61 of the KRAS gene. These mutations are significant because they can play a crucial role in the development and progression of various types of cancer, including colorectal, lung, and pancreatic cancers. By pinpointing these specific genetic alterations, the test aids in determining the most effective treatment strategies for patients, potentially guiding the use of targeted therapies that are more likely to be effective against tumors harboring these mutations.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test leverages advanced molecular techniques to accurately detect the presence of mutations in the KRAS gene. The cost of the KRAS Codon 61 Mutation Detection Test at DNA Labs UAE is 1460 AED. This price reflects the sophisticated technology and expertise required to conduct such a precise genetic analysis. For patients and healthcare providers, the test represents a valuable tool in the personalized medicine approach, offering insights that can significantly impact treatment decisions and outcomes in cancer care.
The Ribosomal P Antibody Test is a specialized blood test designed to detect the presence of ribosomal P protein antibodies in the bloodstream. These antibodies are significant because their presence is often associated with certain autoimmune diseases, particularly systemic lupus erythematosus (SLE). In patients with SLE, the immune system mistakenly targets the body's own tissues, leading to inflammation and damage. The detection of ribosomal P antibodies can aid in the diagnosis and management of SLE, providing valuable information about the patient's condition and guiding treatment decisions.
The test involves taking a blood sample from the patient, which is then analyzed in a laboratory to determine the presence of these specific antibodies. It's a crucial tool in the diagnostic process, helping healthcare providers to differentiate between various autoimmune conditions and to assess the severity and progression of the disease.
At DNA Labs UAE, the Ribosomal P Antibody Test is available for a cost of 1460 AED. DNA Labs UAE is known for its state-of-the-art facilities and commitment to providing accurate, reliable, and timely diagnostic services. By offering this test, DNA Labs UAE supports patients and healthcare providers in the effective management of autoimmune diseases, ensuring that individuals receive the appropriate care and treatment based on their specific diagnostic results.
The Amino Acid Non-Ketotic Hyperglycinemia Panel Quantitative CSF and Plasma Test is a specialized diagnostic assessment performed to detect Non-Ketotic Hyperglycinemia (NKH), a rare genetic metabolic disorder primarily affecting the nervous system. This condition is characterized by an excessive accumulation of glycine in the body due to the inability to break it down effectively, leading to severe neurological symptoms. The test involves the quantitative analysis of glycine levels in both the cerebrospinal fluid (CSF) and plasma, providing crucial information for the diagnosis and management of NKH.
Performed at DNA Labs UAE, this comprehensive panel is essential for identifying the disorder early, especially in newborns and young children who are most at risk. The test cost is set at 1460 AED, reflecting the specialized nature of the analysis and the advanced technology utilized in the process. Early detection and diagnosis through this test can significantly impact the treatment approach and improve the quality of life for individuals affected by Non-Ketotic Hyperglycinemia.
The GAD-65 (Glutamic Acid Decarboxylase-65) IgG Test is a specialized diagnostic procedure aimed at detecting antibodies against the enzyme glutamic acid decarboxylase (GAD) in the blood. GAD plays a crucial role in the synthesis of gamma-aminobutyric acid (GABA), a neurotransmitter involved in regulating nerve signals in the brain. The presence of GAD-65 antibodies is commonly associated with autoimmune disorders, including type 1 diabetes and certain neurological conditions such as Stiff Person Syndrome.
This test is particularly significant for individuals exhibiting symptoms suggestive of these autoimmune disorders or for those with a family history of type 1 diabetes, as it helps in the early detection and management of the condition. The test involves drawing a blood sample from the patient, which is then analyzed for the presence of GAD-65 IgG antibodies.
At DNA Labs UAE, the GAD-65 IgG Test is available for a cost of 1450 AED. The laboratory is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable test results. Patients opting for this test at DNA Labs UAE can expect a seamless experience, from sample collection to the delivery of results, all conducted with the highest standards of care and confidentiality.
The HLA - Narcolepsy DRB1*15 DQB1*0602 DQA1*0102 Test is a specialized diagnostic assessment aimed at identifying specific human leukocyte antigen (HLA) markers that are strongly associated with narcolepsy, a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden sleep attacks. This test focuses on detecting the presence of the HLA-DRB1*15, HLA-DQB1*0602, and HLA-DQA1*0102 alleles, which have been linked to an increased susceptibility to narcolepsy, particularly Type 1 narcolepsy that involves cataplexy (a sudden, temporary loss of muscle tone triggered by strong emotions).
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, this test provides critical insights into an individual's genetic predisposition to narcolepsy, facilitating early detection and the potential for targeted management strategies. The cost of the test is 1450 AED, reflecting the sophisticated technology and expertise required to accurately identify these specific genetic markers. By undergoing this test, individuals who exhibit symptoms of narcolepsy or have a family history of the disorder can gain a clearer understanding of their condition, enabling them to seek appropriate treatment and lifestyle adjustments to manage their symptoms effectively.
The Immune Deficiency Panel 1 Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at evaluating the body's immune system functionality. This test is particularly designed to detect any deficiencies or disorders within the immune system that might make an individual more susceptible to infections, autoimmune diseases, or other immune-related conditions. With a cost of 1450 AED, the test encompasses a comprehensive analysis of various components of the immune system, including but not limited to, the assessment of specific antibodies, immune cell counts, and the functionality of immune responses.
DNA Labs UAE, a leading laboratory in the region, conducts this test with precision and care, ensuring accurate and reliable results. The test is recommended for individuals experiencing frequent infections, unexplained health issues, or those with a family history of immune disorders. It provides crucial insights into the immune system's health, guiding healthcare professionals in devising appropriate treatment plans or preventive measures. The Immune Deficiency Panel 1 Test is a vital tool in understanding and managing immune system-related disorders, contributing to better health outcomes and quality of life.
The Immunotyping Serum Test, available at DNA Labs UAE, is a sophisticated diagnostic procedure priced at 1450 AED. This test is designed to analyze the immune system's characteristics by examining the proteins, or immunoglobulins, present in the blood serum. It is a critical tool for identifying various immune disorders, including autoimmune diseases, immunodeficiency conditions, and allergies. By determining the levels and types of immunoglobulins, healthcare providers can gain valuable insights into a patient's immune system status, aiding in accurate diagnosis and personalized treatment planning. DNA Labs UAE, known for its state-of-the-art facilities and expert medical staff, ensures precise and reliable results, making the Immunotyping Serum Test a valuable resource for patients seeking comprehensive understanding and management of their immune health.
The "NRAS Mutation Codon 12, 13, and 61 Test" is a specialized genetic test offered by DNA Labs UAE, aimed at detecting mutations in specific codons (12, 13, and 61) of the NRAS gene. These mutations are significant because they can play a crucial role in the development and progression of various types of cancer, including melanoma, colorectal cancer, and certain types of leukemia. Identifying mutations in these codons can help in diagnosing these cancers, predicting patient outcomes, and determining the most effective treatment strategies, including targeted therapies.
The test involves analyzing the patient's DNA to look for abnormalities in the NRAS gene that may drive cancer growth. It is particularly useful for oncologists and healthcare professionals in personalizing cancer treatment plans, as NRAS mutations can influence how a patient responds to certain medications.
At DNA Labs UAE, the cost for this comprehensive genetic test is set at 1450 AED. The process is conducted in a state-of-the-art laboratory setting, ensuring high accuracy and reliability of the results. Patients considering this test are usually referred by their healthcare providers, and the results can play a critical role in the management of their condition.
The "Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4 Immune Deficiency Panel 4 Markers Test" is a comprehensive diagnostic procedure offered by DNA Labs UAE, priced at 1450 AED. This advanced testing method combines the precision of Real-Time PCR (Polymerase Chain Reaction) technology with an immune deficiency panel to accurately quantify the RNA levels of the Human Immunodeficiency Virus type 1 (HIV-1) in a patient's blood. Additionally, it evaluates the patient's immune system status by analyzing the CD3 and CD4 markers, which are crucial for assessing the strength and functionality of the immune response. This test is pivotal for early detection, monitoring of infection progression, and guiding effective treatment strategies for individuals living with HIV. By providing a detailed insight into both the viral load and the immune system's condition, healthcare providers can tailor more effective and personalized treatment plans.
Beta Thalassemia is a blood disorder that reduces the production of hemoglobin, an iron-containing protein in red blood cells that carries oxygen to cells throughout the body. Individuals with thalassemia may develop anemia, leading to fatigue and other serious health problems. Given the genetic nature of this condition, prenatal screening is crucial for expecting parents, especially those with a family history of the disease or who are carriers of the thalassemia trait.
The Beta Thalassemia Screening Prenatal Test is a vital procedure offered at DNA Labs UAE, designed to detect the risk of the fetus inheriting beta thalassemia. This test is particularly recommended for couples at increased risk, providing them with essential information on their baby's health and allowing for early intervention if needed.
The test involves collecting a small sample of the mother's blood, which is then analyzed for the presence of mutations associated with beta thalassemia. It is a non-invasive procedure that poses no risk to the fetus.
The cost of the Beta Thalassemia Screening Prenatal Test at DNA Labs UAE is 1450 AED. This investment in prenatal health can offer peace of mind to expecting parents and help in the planning and management of potential health issues related to beta thalassemia. Early detection through this screening can be crucial in ensuring the well-being of both the mother and the child.
